Trial Profile

Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methylphenidate (Primary)
Indications Attention-deficit hyperactivity disorder
Focus Therapeutic Use
Acronyms DS+ADHD Pilot; TEAM-DS

Most Recent Events

02 Jun 2023 Planned End Date changed from 1 Sep 2025 to 30 Sep 2025.
02 Jun 2023 Planned primary completion date changed from 1 Sep 2025 to 30 Sep 2025.
24 May 2023 Planned number of patients changed from 30 to 100.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com